How Eating Disorders Alter Brain Chemistry

Anorexia has the highest mortality rate of any psychiatric disorder. Learn how eating disorders rewire serotonin, dopamine, and reward circuits—and what treatment works.

The InfoNexus Editorial TeamMay 20, 20269 min read

The Deadliest Psychiatric Diagnosis—and Why It's Misunderstood

Anorexia nervosa kills approximately 5–10% of those affected over a 10-year period, giving it the highest mortality rate of any psychiatric disorder. A 2011 meta-analysis published in the Archives of General Psychiatry reported a crude mortality rate of 5.1 deaths per 1,000 person-years—higher than major depressive disorder, schizophrenia, or bipolar disorder. Yet eating disorders are frequently dismissed as lifestyle choices or failures of vanity. The neurobiological evidence accumulated over the past two decades tells a fundamentally different story: eating disorders involve measurable, persistent alterations in brain structure, neurotransmitter function, and reward circuitry that predate and outlast the illness itself.

The Three Primary Disorders: Different but Related

The DSM-5 distinguishes several eating disorders with distinct features, though they share neurobiological underpinnings and commonly transition from one to another.

DisorderCore FeaturesLifetime PrevalenceMortality Rate
Anorexia Nervosa (AN)Severe food restriction, intense fear of weight gain, distorted body image0.6–4.3%5–10% per decade
Bulimia Nervosa (BN)Cycles of binge eating followed by purging behaviors1–3%~2% per decade
Binge Eating Disorder (BED)Recurrent binge eating without compensatory behaviors2–5%Elevated vs. general population; less than AN/BN
Avoidant/Restrictive Food Intake Disorder (ARFID)Food restriction based on sensory or safety concerns, not body image~1–5%Limited data

Women are disproportionately affected, though approximately 25% of binge eating disorder cases occur in men, and male eating disorders are substantially underdiagnosed. LGBTQ+ youth face elevated risk, with rates of disordered eating approximately 4–5 times higher than heterosexual peers.

Serotonin: The Anxiety-Satiety Connection

Serotonin (5-hydroxytryptamine, 5-HT) is central to understanding why eating disorders involve such extreme distress around food. Serotonin regulates both anxiety and satiety—the sensation of fullness. In anorexia nervosa, this creates a neurobiological paradox.

Studies using positron emission tomography (PET) have consistently found that women with anorexia have alterations in the 5-HT1A and 5-HT2A receptor systems, with evidence of reduced serotonin activity in certain pathways. But here is the paradox: eating raises serotonin levels because tryptophan (serotonin's precursor) is an amino acid found in food. For individuals with anorexia who already experience dysregulated, potentially aversive serotonin signaling, restricting food may temporarily reduce an uncomfortable emotional state. Starvation becomes a form of self-medication for anxiety.

This hypothesis—that restriction is negatively reinforced by anxiety reduction—explains why anorexia is so treatment-resistant. The behavior that maintains the disorder is also the behavior that (temporarily) relieves its most distressing symptoms.

Dopamine and the Reward System: Why Food Becomes Threatening

Dopamine drives motivation, reward anticipation, and goal-directed behavior. In healthy individuals, food triggers dopamine release in the nucleus accumbens—the brain's reward hub—creating pleasure and motivating eating. In anorexia, this system malfunctions in a distinctive way.

Kaye et al. (2013) and subsequent neuroimaging studies have found that in anorexia, food stimuli trigger anxiety circuits (including the amygdala and anterior insula) rather than reward circuits. The sight or smell of food generates fear rather than anticipation. Neuroimaging shows hyperactivation of harm avoidance pathways and blunted activation of reward pathways in response to anticipated food reward—an inversion of the normal motivational response to eating.

  • Striatal dopamine D2/D3 receptor binding is altered in recovered anorexia patients, suggesting neurobiological changes that persist after weight restoration
  • Individuals with anorexia show excessive activation in the anterior insula (body sensation processing) when anticipating food consumption
  • The cognitive control networks (prefrontal cortex) are overactivated relative to reward systems, supporting extreme dietary restraint

Bulimia: Disrupted Inhibitory Control

Bulimia nervosa involves a different neurobiological profile. Where anorexia features excessive cognitive control over eating, bulimia involves deficits in inhibitory control combined with heightened reward sensitivity. The binge-purge cycle follows this pattern: serotonin depletion following dietary restriction creates carbohydrate craving; reduced prefrontal inhibition allows binge eating to occur; purging temporarily normalizes serotonin levels and relieves guilt; restriction resumes and the cycle begins again.

Women with bulimia show reduced orbitofrontal cortex volume—a region critical to impulse control and decision-making about reward—compared to healthy controls. Event-related potential (ERP) studies show impaired response inhibition on neuropsychological tasks, suggesting a biological substrate for the difficulty in stopping binge episodes once started.

Brain Structural Changes: Starvation's Neurological Toll

Severe anorexia causes measurable brain atrophy. MRI studies show reductions in gray matter volume, particularly in the frontal and parietal cortex, in patients with active anorexia. White matter volume—the brain's connection infrastructure—is also reduced. Cerebrospinal fluid volume increases as brain tissue shrinks.

These changes are at least partially reversible with weight restoration, but the timeline and completeness of recovery vary. A 2021 study in Psychological Medicine found that gray matter volume normalized in most patients after 14 months of weight restoration, but white matter abnormalities persisted. Cognitive deficits—particularly in attention, memory, and cognitive flexibility—may linger long after physical recovery.

  • The hypothalamus, which regulates hunger, temperature, and hormonal signaling, is directly impaired by malnutrition
  • Cortisol levels are chronically elevated in anorexia, contributing to bone loss (osteoporosis develops in over 50% of patients with long-term anorexia)
  • Amenorrhea (cessation of menstrual periods) occurs when body fat drops below critical levels, mediated by hypothalamic GnRH suppression

Treatment Approaches and Their Evidence Base

Eating disorder treatment is complicated by the neurobiological factors that make engagement difficult—the brain changes that cause the disorder also impair the insight and motivation needed for recovery.

TreatmentTarget DisorderEvidence QualityKey Feature
Family-Based Treatment (FBT/Maudsley)Adolescent ANStrong RCT evidenceParents take control of re-feeding; most evidence in teens
Cognitive Behavioral Therapy (CBT-E)BN, BED, ANStrong for BN, moderate for ANAddresses distorted cognitions and behavioral patterns
Dialectical Behavior Therapy (DBT)BN, BEDModerate evidenceEmotional regulation, distress tolerance
Fluoxetine (Prozac)BN (only FDA-approved medication)RCT evidence60mg/day reduces binge-purge frequency; minimal effect in AN
Lisdexamfetamine (Vyvanse)BED (FDA-approved)RCT evidenceReduces binge episode frequency; originally ADHD medication

Inpatient medical stabilization is required when weight is critically low, electrolyte imbalances are severe (hypokalemia from purging can cause fatal cardiac arrhythmia), or suicide risk is imminent. Refeeding syndrome—a dangerous shift in electrolytes when nutrition is reintroduced too quickly—makes supervised medical refeeding essential for severely malnourished patients.

Recovery is possible. Long-term outcome studies suggest approximately 50% of individuals with anorexia achieve full recovery, 30% partial recovery, and 20% chronic illness. Bulimia has somewhat better outcomes. Early treatment, shorter illness duration before treatment, and absence of comorbid psychiatric diagnoses are associated with better prognosis.

This article is for informational purposes only. Consult a qualified professional for medical guidance on eating disorders.

eating-disordersmental-healthbrain-chemistryneuroscience

Related Articles